The	O
effect	O
of	O
green	B:C1704263
tea	I:C1704263
extract	I:C1704263
supplementation	B:C0242297
on	O
sputum	O
smear	O
conversion	B:C0444785
and	O
weight	B:C0005911
changes	I:C0005911
in	O
pulmonary	B:C0041327
TB	I:C0041327
patients	O
:	O
A	O
randomized	B:C0206035
controlled	I:C0206035
trial	I:C0206035
.	O

Acceleration	O
in	O
sputum	O
smear	O
conversion	B:C0444785
helps	O
faster	O
improvement	O
and	O
decreased	O
probability	O
of	O
the	O
transfer	O
of	O
TB	B:C0041296
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
green	B:C1704263
tea	I:C1704263
extract	I:C1704263
supplementation	B:C0242297
on	O
sputum	O
smear	O
conversion	B:C0444785
and	O
weight	B:C0005911
changes	I:C0005911
in	O
smear	B:C1335447
positive	I:C1335447
pulmonary	B:C0041327
TB	I:C0041327
patients	O
in	O
Iran	B:C0022065
.	O

In	O
this	O
double	O
blind	O
clinical	B:C0008972
study	I:C0008972
,	O
TB	B:C0041296
patients	O
were	O
divided	O
into	O
intervention	B:C0184661
,	O
(	O
n=43	O
)	O
receiving	O
500	O
mg	O
green	B:C1704263
tea	I:C1704263
extract	I:C1704263
(	O
green	B:C1704263
tea	I:C1704263
extract	I:C1704263
)	O
,	O
and	O
control	O
groups	O
(	O
n=40	O
)	O
receiving	O
placebo	B:C1696465
for	O
two	O
months	O
,	O
using	O
balanced	B:C0034656
randomization	I:C0034656
.	O

Random	B:C0034656
allocation	I:C0034656
and	O
allocation	O
concealment	O
were	O
observed	O
.	O

Evaluations	B:C0220825
were	O
performed	O
on	O
three	O
slides	O
,	O
using	O
the	O
ZiehlNeelsen	B:C1318721
method	I:C1318721
.	O

Independent	B:C0871472
and	O
paired	B:C1709451
t	I:C1709451
test	I:C1709451
,	O
McNemar's	B:C0282574
,	O
Wilcoxon	B:C0871608
,	O
Kaplan	O
-	O
Meier	O
,	O
Cox	B:C0010235
regression	I:C0010235
model	I:C0010235
and	O
Log	B:C0282574
-	I:C0282574
Rank	I:C0282574
test	I:C0282574
were	O
utilized	O
.	O

This	O
trial	B:C0008976
was	O
registered	B:C1514821
under	O
IRCT201212232602N11	O
.	O

The	O
interventional	B:C0184661
changes	O
and	O
the	O
interactive	O
effect	O
of	O
intervention	B:C0184661
on	O
weight	O
were	O
not	B:C1273937
significant	I:C1273937
(	O
p>0.05	O
)	O
.	O

In	O
terms	O
of	O
shortening	O
the	O
duration	O
of	O
conversion	B:C0444785
,	O
the	O
case	O
to	O
control	O
proportion	O
showed	O
a	O
significant	O
difference	O
(	O
p=0.032	O
)	O
.	O

Based	O
on	O
the	O
Cox	B:C0010235
regression	I:C0010235
model	I:C0010235
,	O
the	O
hazard	O
ratio	O
of	O
the	O
relative	O
risk	O
of	O
delay	O
in	O
sputum	O
smear	O
conversion	B:C0444785
was	O
3.7	O
(	O
p=0.002	O
)	O
in	O
the	O
higher	O
microbial	O
load	O
group	B:C1257890
compared	O
to	O
the	O
placebo	B:C1696465
group	B:C1257890
and	O
0.54	O
(	O
95	O
%	O
CI	O
:	O
0.31	O
-0.94	O
)	O
in	O
the	O
intervention	B:C0184661
compared	O
to	O
the	O
placebo	B:C1696465
group	B:C1257890
.	O

green	B:C1704263
tea	I:C1704263
extract	I:C1704263
decreases	B:C0442797
the	O
risk	O
of	O
delay	O
in	O
sputum	O
smear	O
conversion	B:C0444785
,	O
but	O
has	O
no	O
effect	O
on	O
weight	B:C0043094
gain	I:C0043094
.	O

Moreover	O
,	O
it	O
may	O
be	O
used	O
as	O
an	O
adjuvant	B:C0677850
therapy	I:C0677850
for	O
faster	O
rehabilitation	O
for	O
pulmonary	B:C0041327
TB	I:C0041327
patients	O
.	O

